By
AmyT on
November 14, 2012
Well, here we are — World Diabetes Day 2012!
Today, we mark the anniversary of the day the co-creator of insulin, Dr. Frederick Banting, was born back in 1891. While World Diabetes Day has been around for more than two decades, founded by the International Diabetes Federation, it really started getting noticed in 2007, when the United Nations issued a resolution and made it an official day of observance.
Five years later, the community has grown…
Read more »
By
AmyT on
November 11, 2010
Many of us patient advocates who make the rounds at e-patient and health 2.0 conferences hear an awful lot of talk about “what the patient wants” and how Pharma and device companies should reach out to our communities online. Meanwhile, they’ve been slow to embrace Social Media, and given the controversy over FDA regulations for this, who knows what’s happening internally at these companies as they struggle to form a viable strategy for getting involved?…
Read more »
By
AmyT on
April 19, 2010
Thankfully, many readers send me emails when they hear about something newsworthy/ different/ fun/ controversial/ or quirky in the world of diabetes. Thank you! And keep those tips coming, pahhhleeese, People.
Today, from the mailbag, three items that I simply had to share:
New OneTouch Delica Lancing Device
This one’s so new it doesn’t even appear on the JNJ OneTouch website yet — but appears to available via DiabeticPromotions.
According to my reader tip: “At first…
Read more »
By
AmyT on
January 6, 2010
What went through your mind when you heard about the sudden death of Johnson & Johnson heiress Casey Johnson a few days ago? I can’t imagine a Type 1 diabetic out there who isn’t shuddering in their shoes. She was only 30 years old, for goodness’ sake, and despite the drugs and alcohol, she’d likely be alive today if her diabetes hadn’t played some role.
There’s been a ton of speculation since Casey, a prominent…
Read more »
By
AmyT on
January 5, 2010
At the end of last year (so, basically, two weeks ago), the Juvenile Diabetes Research Foundation announced a joint partnership with the Johnson & Johnson Corporate Office of Science and Technology to help with the discovery and development of drugs to promote beta cell survival. The program will look to fund research at academic centers around the world that could eventually lead to novel new drugs for the prevention and treatment of type 1 diabetes.
Sounds…
Read more »
